☰

Brian G. Blair, Ph.D. - Publications

Affiliations: 
2002-2004 Oncology Johns Hopkins University School of Medicine, Baltimore, MD, United States 
 2004-2009 Biomedical Sciences University of California, San Diego, La Jolla, CA 
 2010-2014 Oncology Johns Hopkins University School of Medicine, Baltimore, MD, United States 
 2020- Bioengineering University of Maryland, College Park, College Park, MD 
Area:
Cell Biology
Tree Info Grants Similar researchers PubMed Report error

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Zahari MS, Wu X, Blair BG, Pinto SM, Nirujogi RS, Jelinek CA, Malhotra R, Kim MS, Park BH, Pandey A. Activating mutations in PIK3CA lead to widespread modulation of the tyrosine phosphoproteome. Journal of Proteome Research. PMID 26267517 DOI: 10.1021/Acs.Jproteome.5B00302  0.618
2015 Blair BG, Wu X, Zahari MS, Mohseni M, Cidado J, Wong HY, Beaver JA, Cochran RL, Zabransky DJ, Croessmann S, Chu D, Toro PV, Cravero K, Pandey A, Park BH. A phosphoproteomic screen demonstrates differential dependence on HER3 for MAP kinase pathway activation by distinct PIK3CA mutations. Proteomics. 15: 318-26. PMID 25367220 DOI: 10.1002/Pmic.201400342  0.746
2014 Mohseni M, Cidado J, Croessmann S, Cravero K, Cimino-Mathews A, Wong HY, Scharpf R, Zabransky DJ, Abukhdeir AM, Garay JP, Wang GM, Beaver JA, Cochran RL, Blair BG, Rosen DM, et al. MACROD2 overexpression mediates estrogen independent growth and tamoxifen resistance in breast cancers. Proceedings of the National Academy of Sciences of the United States of America. 111: 17606-11. PMID 25422431 DOI: 10.1073/Pnas.1408650111  0.699
2014 Beaver JA, Jelovac D, Balukrishna S, Cochran RL, Croessmann S, Zabransky DJ, Wong HY, Valda Toro P, Cidado J, Blair BG, Chu D, Burns T, Higgins MJ, Stearns V, Jacobs L, et al. Detection of cancer DNA in plasma of patients with early-stage breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 2643-50. PMID 24504125 DOI: 10.1158/1078-0432.Ccr-13-2933  0.721
2014 Blair BG, Bardelli A, Park BH. Somatic alterations as the basis for resistance to targeted therapies Journal of Pathology. 232: 244-254. PMID 24114654 DOI: 10.1002/Path.4278  0.519
2013 Wang GM, Wong HY, Konishi H, Blair BG, Abukhdeir AM, Gustin JP, Rosen DM, Denmeade SR, Rasheed Z, Matsui W, Garay JP, Mohseni M, Higgins MJ, Cidado J, Jelovac D, et al. Single copies of mutant KRAS and mutant PIK3CA cooperate in immortalized human epithelial cells to induce tumor formation. Cancer Research. 73: 3248-61. PMID 23580570 DOI: 10.1158/0008-5472.Can-12-1578  0.65
2012 Higgins MJ, Jelovac D, Barnathan E, Blair B, Slater S, Powers P, Zorzi J, Jeter SC, Oliver GR, Fetting J, Emens L, Riley C, Stearns V, Diehl F, Angenendt P, et al. Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 3462-9. PMID 22421194 DOI: 10.1158/1078-0432.Ccr-11-2696  0.622
2011 Higgins MJ, Jelovac D, Barnathan E, Blair B, Slater S, Powers P, Zorzi J, Jeter SC, Oliver GR, Diehl F, Angenendt P, Huang P, Argani P, Murphy K, Wolff AC, et al. Improving detection methods for PIK3CA mutations in breast cancer using peripheral blood from patients with metastastic breast cancer (MBC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 10512. PMID 28021790 DOI: 10.1200/Jco.2011.29.15_Suppl.10512  0.641
2011 Blair BG, Larson CA, Adams PL, Abada PB, Pesce CE, Safaei R, Howell SB. Copper transporter 2 regulates endocytosis and controls tumor growth and sensitivity to cisplatin in vivo. Molecular Pharmacology. 79: 157-66. PMID 20930109 DOI: 10.1124/Mol.110.068411  0.588
2010 Larson CA, Adams PL, Blair BG, Safaei R, Howell SB. The role of the methionines and histidines in the transmembrane domain of mammalian copper transporter 1 in the cellular accumulation of cisplatin. Molecular Pharmacology. 78: 333-9. PMID 20519567 DOI: 10.1124/Mol.110.064766  0.514
2010 Larson CA, Adams PL, Jandial DD, Blair BG, Safaei R, Howell SB. The role of the N-terminus of mammalian copper transporter 1 in the cellular accumulation of cisplatin. Biochemical Pharmacology. 80: 448-54. PMID 20451502 DOI: 10.1016/J.Bcp.2010.04.030  0.512
2010 Blair BG, Larson CA, Adams PL, Abada PB, Safaei R, Howell SB. Regulation of copper transporter 2 expression by copper and cisplatin in human ovarian carcinoma cells. Molecular Pharmacology. 77: 912-21. PMID 20194531 DOI: 10.1124/Mol.109.062836  0.485
2010 Larson CA, Adams PL, Jandial DD, Blair BG, Safaei R, Howell SB. Corrigendum to " The role of the N-terminus of mammalian copper transporter 1 in the cellular accumulation of cisplatin" [Biochem. Pharmacol. 80 (2010) 448-454] Biochemical Pharmacology. 80: 1768. DOI: 10.1016/J.Bcp.2010.08.006  0.483
2009 Blair BG, Larson CA, Safaei R, Howell SB. Copper transporter 2 regulates the cellular accumulation and cytotoxicity of Cisplatin and Carboplatin. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 4312-21. PMID 19509135 DOI: 10.1158/1078-0432.Ccr-09-0311  0.494
2009 Safaei R, Maktabi MH, Blair BG, Larson CA, Howell SB. Effects of the loss of Atox1 on the cellular pharmacology of cisplatin. Journal of Inorganic Biochemistry. 103: 333-41. PMID 19124158 DOI: 10.1016/J.Jinorgbio.2008.11.012  0.515
2009 Larson CA, Blair BG, Safaei R, Howell SB. The role of the mammalian copper transporter 1 in the cellular accumulation of platinum-based drugs. Molecular Pharmacology. 75: 324-30. PMID 18996970 DOI: 10.1124/Mol.108.052381  0.544
2008 Abukhdeir AM, Vitolo MI, Argani P, De Marzo AM, Karakas B, Konishi H, Gustin JP, Lauring J, Garay JP, Pendleton C, Konishi Y, Blair BG, Brenner K, Garrett-Mayer E, Carraway H, et al. Tamoxifen-stimulated growth of breast cancer due to p21 loss. Proceedings of the National Academy of Sciences of the United States of America. 105: 288-93. PMID 18162533 DOI: 10.1073/Pnas.0710887105  0.75
2006 Huang Y, Keen JC, Pledgie A, Marton LJ, Zhu T, Sukumar S, Park BH, Blair B, Brenner K, Casero RA, Davidson NE. Polyamine analogues down-regulate estrogen receptor alpha expression in human breast cancer cells. The Journal of Biological Chemistry. 281: 19055-63. PMID 16679312 DOI: 10.1074/Jbc.M600910200  0.639
2006 Abukhdeir AM, Blair BG, Brenner K, Karakas B, Konishi H, Lim J, Sahasranaman V, Huang Y, Keen J, Davidson N, Vitolo MI, Bachman KE, Park BH. Physiologic estrogen receptor alpha signaling in non-tumorigenic human mammary epithelial cells. Breast Cancer Research and Treatment. 99: 23-33. PMID 16541319 DOI: 10.1007/S10549-006-9177-0  0.63
2005 Keen JC, Zhou Q, Park BH, Pettit C, Mack KM, Blair B, Brenner K, Davidson NE. Protein phosphatase 2A regulates estrogen receptor alpha (ER) expression through modulation of ER mRNA stability. The Journal of Biological Chemistry. 280: 29519-24. PMID 15965230 DOI: 10.1074/jbc.M505317200  0.576
2004 Bachman KE, Argani P, Samuels Y, Silliman N, Ptak J, Szabo S, Konishi H, Karakas B, Blair BG, Lin C, Peters BA, Velculescu VE, Park BH. The PIK3CA gene is mutated with high frequency in human breast cancers. Cancer Biology & Therapy. 3: 772-5. PMID 15254419 DOI: 10.4161/Cbt.3.8.994  0.678
2004 Bachman KE, Blair BG, Brenner K, Bardelli A, Arena S, Zhou S, Hicks J, De Marzo AM, Argani P, Park BH. p21(WAF1/CIP1) mediates the growth response to TGF-beta in human epithelial cells. Cancer Biology & Therapy. 3: 221-5. PMID 14726675  0.564
Show low-probability matches.